Evidence map›Paper›PMID 38524029›Full record

ArticleCureus2024

Assessment of the Practices and Perspectives of Healthcare Providers Towards Utilization of Telemedicine for the Care of Adult Patients With Diabetes Mellitus During the COVID-19 Pandemic in India.

Shubham Atal, Sowrabha Bhat, Sayan Kumar Das, Rajnish Joshi, Aditi Pandit Kabde, Aishwarya Krishnamurthy, Tejal Lathia, Balakrishnan Sadasivam, Rukiya Surya Shaikh

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 3 countries.

Shubham AtalPharmacology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Sowrabha BhatEndocrinology, Diabetes and Metabolism, Yenepoya Medical College Hospital, Mangalore, IND.
Sayan Kumar DasPharmacology, Manipal Tata Medical College, Jamshedpur, IND.
Rajnish JoshiInternal Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Aditi Pandit KabdeEndocrinology, Narayana Superspeciality Hospital, Nanded, IND.
Aishwarya KrishnamurthyEndocrinology, Max Superspecialty Hospital, Ghaziabad, IND.
Tejal LathiaEndocrinology, Apollo and Cloud Nine Hospitals, Navi Mumbai, IND.
Balakrishnan SadasivamPharmacology, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Rukiya Surya ShaikhEndocrinology, Blue Circle Clinic, Mumbai, IND.
All India Institute of Medical Sciences Bhopal · INApollo Hospitals · INApollo Hospitals · INApollo Hospitals · INGreen Circle · CZMax Super Speciality Hospital · INNethradhama Superspeciality Eye Hospital · INYenepoya University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose The lockdowns and restrictions enforced periodically during the COVID-19 pandemic posed a serious challenge for non-COVID care, especially in diabetes where telediabetes, the utilization of telemedicine consultations for diabetic care, became more necessary than ever before. Although studies have shed light on the perception of patients, there is a paucity of studies from the perspective of healthcare providers, especially in an Indian context. Moving forward, it is imperative to understand the perspectives of telediabetes providers in this domain. Hence, a nationwide survey was carried out to assess providers' practices and perspectives towards using telemedicine for providing diabetes care in India during the COVID-19 pandemic and beyond. Methods An online questionnaire-based, cross-sectional study was carried out involving diabetes care physicians. The study tool was developed after the identification of broad themes and constructs from published literature, national guidelines, and diabetes experts' recommendations, following which, it was validated by six experts and pilot-tested. An online open survey, hosted on a professional platform, was circulated to internists, endocrinologists, and other diabetes care physicians of various institutions, hospitals, and clinics from both public and private sectors across the country through individual and group emails and various mobile messenger services. Results Out of the 239 doctors who responded to the survey, 195 (81.6%) had provided telediabetes services since the COVID-19 outbreak, and 84.1% were actively providing teleconsultations for diabetes at the time of the survey. The majority of participants (63.2%) were private practitioners. Telediabetes engagement was 3.5 hours per day at the peak of the pandemic and reduced significantly to one hour after the end of the pandemic. Video calling was the most preferred modality for consultation, whereas messaging services were preferred for input from the patients. Printed prescription images followed by text messages were the common modalities for sending treatment advice. The overall perception towards telediabetes was positive (50.1%). Most physicians reported being reasonably and somewhat aware (65.6% and 20.5%, respectively) of telemedicine practice guidelines but were not sure about the extent of compliance. Conclusions Our study sheds light not only on the utilization of telediabetes from physicians' perspectives and practices but also on its acceptability while identifying areas requiring clarity and focus moving forward.

Indexed as

diabetesehealthtelecaretelediabetestelehealth

Identifiers

PMID38524029
PMCPMC10961156
OpenAlexW4392109858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.